Alkem Laboratories Establishes Wholly Owned Subsidiary in UAE for International Expansion
Alkem Laboratories Limited has announced the incorporation of a Wholly Owned Subsidiary (WOS) in Dubai, UAE. The new entity, named Alkem Pharma Trading FZCO, marks a strategic move to strengthen the company’s global reach in the pharmaceutical sector.Alkem Pharma Trading FZCO has been incorporated with the primary objective of exporting the company’s products to African, South East Asian, and non-UAE markets. This subsidiary falls under the Pharmaceuticals industry.
The establishment details highlight the full ownership stake and initial capital structure of the new venture.
Key details regarding the subsidiary include:
| Particulars | Detail |
|---|---|
| WOS Name | Alkem Pharma Trading FZCO ('Alkem Pharma') |
| Industry | Pharmaceuticals |
| Incorporation Location | Dubai, UAE |
| Total Shareholding Acquired | 100% |
| Consideration Form | Cash |
The financial structure of Alkem Pharma Trading FZCO is as follows:
| Parameter | Amount / Details |
|---|---|
| Authorized Share Capital | AED 36,70,000 (3,67,000 Equity Shares of AED 10 each) |
| Subscribed Capital | AED 36,70,000 (3,67,000 Equity Shares of AED 10 each) |
| Cost of Acquisition | AED 3,670,000 (Subscription of 3,67,000 Equity Shares of AED 10 each) |
Alkem Pharma, being a WOS, is considered a related party of Alkem Laboratories Limited. The incorporation of the subsidiary aims to facilitate the export of the company’s products to key international markets beyond the UAE.
ALKEM Stock Price Movement
Alkem Laboratories Limited shares today slipped by 1.67% to settle at ₹5349. The stock closed after trading on a notable volume of 165,462 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.